4Bonin SR, Lanciano RM, Corn BW, et al. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of eervioal cancer with radiotherapy. Int J Radiat Oncol Biol Phys,1996,34:167-172.
5Pendlebury SC, Cahill S, Crandon A J, et al. Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. Int J Radiat Oncol Biol Phys, 1993,27:959-962.
6Finlay MH, Ackerman I, Tirona RG, et al. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node corverage of conventional pelvic dields baded on bony landmarks. Int J Radiat Oncol Biol Phys, 2006,64:205-209.
7Taylor A, Rockall AG, Reznek RH, et al. Mapping pelvic lymph nodes:guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys,2005 ,63 :1604-1612.
8Chao CKS, Lin M. Lymphangiogram-assisted lymph node targvt delineation for patients with gynecology malignancies. Int J Radiat Oncol Biol Phys,2002,54 : 1147-1152.
9Greer BE, Wui-Jin K, Figge DC, et al. Gynecologic radiotherapy fields defined by intra-opemtive measurements. Gynecol Oncol, 1990,38:421-424.
10Yazici G, Yildiz F, Cengiz M, et al. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks:in regard to Finlay MH, Ackerman I, Tirona RG, et al ( Int J Radiat Oncol Biol Phys, 2006,64 : 205-209 ). Int J Radiat Oncol Biol Phys,2006,65 : 1594-1595.
